Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
7
×
texas blog main
7
×
san diego blog main
san diego top stories
texas top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
praluent
alzheimer's
donald trump
fda
merck
pbm
regeneron pharmaceuticals
rejection
sanofi
vc
abeona therapeutics
affordable care act
agios pharmaceuticals
What
healthcare
7
×
bio
roundup
based
american
best
continue
crash
debate
industry
kind
moves
nash
people
pharmaceutical
policy
politicians
pressure
scalps
trump’s
u.s
accelerator
additional
america
announced
backing
becker
billions
biogen
capital
cholesterol
chosen
class
cleveland
closes
cohort
continues
convoluted
dallas
debuts
Language
unset
Current search:
" national blog main "
×
healthcare
×
" texas blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com
5 years ago
Health Wildcatters Splits Program in Two, Debuts Latest Startup Class